In a statement, the U.S. Department of Justice said, Novartis AG has agreed to settle U.S. government charges that it had made illegal transfers, in the nature of kickbacks, to doctors and patients, in order to boost drug sales. Swiss… Read More ›
Vas Narasimhan
Novartis faces shareholder ire at AGM over skyrocketing drug prices
Shareholders are scheduled to vote on Novartis’s planned spin-off of its Alcon eye care unit. On Thursday, at the annual general meeting of Swiss drugmaker Novartis, shareholders came in heavily at the drugmaker for the hike in drug prices. Novartis… Read More ›
Swiss pharmaceutical giant Novartis appoints Susanne Schaffert to lead its oncology business
Susanne Schaffert will be replacing Liz Barrett who will return to the U.S. to head a U.S. biotech firm. Swiss pharmaceutical giant Novartis has stated, it has appointed Susanne Schaffert, a veteran, as the head of its oncology business. She… Read More ›
Vas Narasimhan, Novartis’s new CEO pushing for immersion of technology at the Swiss pharmaceutical firm
The elevation of key human resource personnel to Novartis’s board suggests that Vas Narasimhan is aiming to turn a new leaf at the Swiss pharmaceutical giant. Vas Narasimhan, Novartis’s new CEO is strategically changing the leadership in the Swiss drugmaker…. Read More ›
manageria.biz 